ABSTRACT Drosophila melanogaster males have one X chromosome, while females have two. To compensate for the resulting disparity in X-linked gene expression between the two sexes, most genes from the male X chromosome are hyperactivated by a special dosage compensation system. Dosage compensation is achieved by a complex of at least six proteins and two noncoding RNAs that specifically associate with the male X. A central question is how the X chromosome is recognized. According to a current model, complexes initially assemble at ‫53ف‬ chromatin entry sites on the X and then spread bidirectionally along the chromosome where they occupy hundreds of sites. Here, we report that mutations in Trithorax-like (Trl) lead to the loss of a single chromatin entry site on the X, male lethality, and mislocalization of dosage compensation complexes.
D
ROSOPHILA melanogaster males have one X chroal. 1995) are degraded and the dosage compensation complex is not assembled on the X chromosomes of mosome, while females have two. To compensate for this disparity in gene dose, there are mechanisms females. Msl2 can be ectopically expressed in females by deleting the Sxl-binding sites in the msl2 mRNA unto ensure that X-linked genes are expressed at the same level in the two sexes. One of these mechanisms is the translated regions (Kelley et al. 1995) . MSL complexes are then assembled on the X, resulting in a partial loss hyperactivation of genes on the male X chromosome by a special dosage compensation system (reviewed in of female viability (Kelley et al. 1995) . The lethal effects of ectopic Msl2 can be suppressed by reducing the dose Lucchesi and Manning 1987; Baker et al. 1994 ; Cline and Meyer 1996; Kelley and Kuroda 2000; Pannuti of msl1 (Kelley et al. 1995; Lyman et al. 1997) or mof (Hilfiker et al. 1997) . A similar effect can be achieved and Lucchesi 2000). Hyperactivation of X-linked genes in males is mediated by the male-specific-lethal (MSL) by eliminating mle or msl3 activity (Kelley et al. 1995) . While a good deal is known about the assembly and complex, which consists of at least six proteins, Msl1, Msl2, and Msl3, maleless (Mle; reviewed in Lucchesi mechanism of action of the MSL dosage compensation complex, it is not fully understood how the complex is and Manning 1987; Baker et al. 1994) , males absent on the first (Mof; Hilfiker et al. 1997) , and JIL-1 (Jin specifically targeted to the X chromosome. The current model is based on the observation that in the absence of et al. 2000) , as well as two noncoding RNAs, roX1 and roX2 (Franke and Baker 1999; Meller et al. 2000) . msl3, mle, or mof, Msl1 and Msl2 associate with ‫53ف‬ special, high-affinity sites on the X chromosome (Palmer et al. Assembly of the dosage compensation complex on the X chromosome results in preferential association of an 1993; Gorman et al. 1995; Lyman et al. 1997; Gu et al. 1998) . Two of these sites correspond to the roX1 and acetylated form of histone H4 with the X (Bone et al. 1994) and hyperactivation of most X-linked genes (LucroX2 genes (Kelley et al. 1999) . When moved to the autosomes, transgenes bearing copies of roX1 and roX2 chesi and Manning 1987; Baker et al. 1994) . In females, the Sex-lethal (Sxl) gene turns off the male dosage cominitiate binding and, in some cases, spreading of the dosage compensation complex into adjacent chromatin pensation system by repressing msl2 translation (Bashaw and Baker 1997; Kelley et al. 1997) . In the absence of (Kelley et al. 1999; Meller et al. 2000; Henry et al. 2001; Kageyama et al. 2001) . These data led to a proMsl2, Msl1 and Msl3 (Gorman et posal (Kelley et al. 1999 ) that the high-affinity sites, termed "chromatin entry sites," serve as assembly points of the dosage compensation complex from which it each combination of alleles the ratio was not significantly
Genes that function not only in dosage compensation different between genetic backgrounds (data not shown).
but also in processes vital to both sexes would not be tion that were used as described in Figure 2a and Table 1 . (Wang et al. 2001) . It was first characterized as a protein Trl Ϫ is either Trl 62 (for crosses described in Figure 2a and the enriched on the X chromosome ( Jin et al. 1999 ) and top of Table 1) or Trl 13C for the cross described in the bottom turned out to be part of the MSL complex ( Jin et al. of Table 1 (for the latter cross, TM3,Ser balancer chromosome   2000) . Null mutations in jil-1 are sex nonspecifically was used).
To ensure that any effects seen in the experiment outlined lethal. However, males homozygous for a hypomorphic above were not due to differences in genetic background, the allele of the gene are less viable than their sibling fefollowing control cross was performed:
males, although the females also display reduced viability (Wang et al. 2001 ). Another gene that appears to function in both dosage 
nucleosome-free regions of chromatin both in vitro
The male:female ratios were compared as shown in Figure 1c . (Tsukiyama et al. 1994) and in vivo and is required for , can produce viable adults at a low frequency (Farkas et al. 1994; Bhat et al. 1996) . In the reduction in Trl activity is more deleterious to males
Western blots: Extract from ‫5.2ف‬ third instar larvae was than to females, we hypothesized that this gene may be loaded on an 8% polyacrylamide gel (PAGE). Western blotting involved in MSL-mediated dosage compensation. In the was performed as described in Deshpande et al. (1995) . Blots were probed with 1:3000 dilution of Msl1 (Palmer et al. 1994) study reported here, we found that, in addition to male antibody as described in Gorman et al. (1995) . For a loading lethality, a reduction in Trl function results in the loss control, equal amounts of extract were loaded on a 12% PAGE of a single X chromosome chromatin entry site and the and probed with 1:15 dilution of anti-snf monoclonal antibody redistribution of the MSL complex to autosomes. These 4G3 (Deshpande et al. 1996) support for the idea that a reduction in Trl activity may female ratios between crosses (such as in Figure 2 , a and c, compromise the dosage compensation system comes and Figure 1a were computed using the normal approximahomozygous males. Normally, Trl 13C homozygous males tion of the binomial distribution.
are as viable as their sibling females ( Figure 1a) ; however, when the dose of msl1, msl2, and mle is simultaneously halved, the viability of the Trl 13C homozygous males RESULTS is significantly reduced compared to their sibling females ( Figure 1c ). 
/Trl
62 mutant combithan half of the homozygotes survive to the adult stage (Farkas et al. 1994; Bhat et al. 1996) and these display a nation, no effects were observed for a mutation in mle ( Figure 1b ). This is most likely due to the fact that the variety of other phenotypes. These phenotypes become markedly more severe when is combined with one of these two stronger Trl alleles. If the male lethality of Trl mutations is enhanced by reducing the amount of the MSL complex, we reasoned As illustrated in Figure 1a, . as H83M2 transgene; Kelley et al. 1995) . Sibling Trl mutant males with or without the transgene were comSince sex-specific lethality in flies is usually associated with upsets in X chromosome dosage compensation, one pared to ensure uniformity of genetic background (see materials and methods). We found that the introducpossible explanation for the male lethal effects of these two Trl mutant combinations is that the reduction in Trl tion of the H83M2 transgene into the Trl mutant backgrounds improves male viability ( Figure 1d ). Although activity somehow perturbs the functioning of the msl dosage compensation system. If this is the case, one would small, the effects on male viability were consistent. Moreover, we observed an increase in male viability in two predict that the male lethal effects seen in these two Trl mutant combinations would be exacerbated by reducing different combinations of Trl alleles with two independent lines of the H83M2 transgene ( Figure 1d ). the dose of the msl genes. In an otherwise wild-type background, mutations in msl1 and msl2 are not haploTrl mutant males possess a functional MSL complex: One explanation for these gene dose effects is that Trl insufficient, and heterozygous mutant males show little or no reduction in viability (not shown). However, as is required for the expression of a limiting component(s) of the MSL complex. To test this hypothesis, indicated in Figure 1b and Table 1 
62 background relative to female siblings of the same genotype. Additional data are provided in Table 1 . The control (msl ϩ ) flies were generated from parents carrying the CyO balancer to control for any background effects (see materials and methods for cross details). To ensure statistical significance, at least 100 flies of the appropriate Trl and msl genotype were scored. P values were calculated using the two-tailed Fisher's exact test. (c) msl1 msl2 mle triple-mutant chromosome induces male-specific lethality (Kelley et al. 1995) . Comparison was performed on sibling males (see materials and methods). To ensure that the results are statistically significant, at least 100 Trl mutant flies were scored for each cross. P values were calculated using the 2 test.
reduced or because Trl is required for the assembly of Figure 2b (growth at 22Њ), females carrying a single copy of the H83M2 transgene that are either wild type or functional complexes. If either of these scenarios were correct, then mutations in Trl would be expected to heterozygous for Trl 13C are almost fully viable (see legend to Figure 2 ). In contrast, when they are homozygous suppress the lethal effects of ectopically expressing Msl2 protein in females from the H83M2 transgene. Contrary for Trl
13C
, there is a marked reduction in viability. For the H83M2-87A transgene line, viability is reduced to to this prediction, we found that Trl mutations enhance rather than suppress the lethal effects of the H83M2 Ͻ50% of the Trl 13C females lacking the transgene, while it is Ͻ10% for the H83M2-6I line. Even more striking transgene.
Under the conditions of the experiment shown in reductions in viability are evident in H83M2 females . plexes are entirely missing, our assay is not sufficiently quantitative to detect modest reductions (two-to fourfold) In both of these cases, Trl mutant females carrying the transgene are never observed. The effects on female in the amount of MSL complexes associated with the X chromosome or even with specific regions of the X viability are unlikely to be due to some nonspecific interaction of the transgene with Trl, since female lethality chromosome. That the loading of the MSL complexes onto the X chromosome is, in fact, perturbed in Trl can be rescued by reducing the dose of msl1 by half or by eliminating the function of either msl1 or mle (data not mutant males is suggested by the finding that the number of autosomal sites bound by MSL complexes is inshown). These findings argue that the level and at least the global activity of the MSL complexes is not likely to creased. This is illustrated in Figure 4, , the sites in Trl mutant males: Another hypothesis is that Trl may be required for association of the MSL complex number of autosomal sites for Msl1 is 15 Ϯ 1 and for Msl2 is 11 Ϯ 1. This increase in the number of autosomal with a subset of the ‫002ف‬ sites on the male X chromosome. To explore this possibility, we first compared the sites does not seem to be due to some nonspecific lethal effects in this Trl mutant combination because a similar distribution of GAGA (Trl) protein and MSL complexes on polytene chromosomes from wild-type males. Double increase is evident in the Trl 13C /Trl 2.3 mutant combination (see Figure 4b) . Additional evidence for abnormalilabeling experiments revealed that only 6 of the ‫05ف‬ X chromosomal sites bound by GAGA also have MSL ties in the distribution of the MSL complexes comes from the presence of MSL complexes at a site in the complexes (Figure 3a) . We next compared the distribution of MSL complexes on polytene chromosomes from 3C region of the X chromosome of Trl mutant males that is unoccupied in wild-type males (Figure 3b , we attempted to reduce the level of functional GAGA factor as much as possible.
and Trl Ϫ females that ectopically express Msl2 protein from the H83M2 transgene ( Figure 4c) Figure 4b ). One chromatin entry site is missing in Trl mutant the distribution of MSL complexes on the mutant X chromosome even at the sites that contain GAGA promales: Although Trl Ϫ males displayed no striking irregularities in the distribution of MSL complexes on the X tein ( Figure 3b ). While there are no regions of the X chromosome in the Trl mutants in which MSL comchromosome, the presence of complexes at ectopic sites 1999; Meller et al. 2000) . Since msl Ϫ males produce poor polytene chromosomes, females that express the Msl2 protein in the appropriate msl mutant background are usually used to visualize entry sites. It is thought that the location of the entry sites in the two sexes is the same. Two of the ‫53ف‬ chromatin entry sites on the X chromosome correspond to the genes encoding roX1 (position 3F) and roX2 (position 10C) RNAs, while the identity of the remaining sites is unknown. Both roX1 and roX2 have several (GA) n /(CT) n motifs that should be recognized by the GAGA factor. Moreover, these motifs are thought to be important for entry site function and are in hypersensitive sites in chromatin from male flies ). Thus we expected to observe colocalization of GAGA and Msl complexes at the roX1 and roX2 entry sites. Contrary to these expectations, we could not detect GAGA in the vicinity of roX2. Although GAGA protein could be detected very near to the roX1 entry site, the GAGA signal did not appear to directly overlap with the Msl signal. This would suggest that the GAGA factor does not colocalize with the Msl complex at the roX1 entry site. Of the remaining ‫33ف‬ entry sites, GAGA protein and the Msl complex appeared to colocalize only at one site, which is at 12DE. In unstretched chromosomes, GAGA protein and the MSL entry site at 12DE overlap; however, in favorable preparations (see Figure 5a ) the GAGA band resolves into a tight "doublet" with the MSL complex in between. the binding of MSL complexes to X chromosome entry differ from those described in Kelley et al. (1995) . First, we sites in Trl Ϫ was identical to that in wild type except for reared our flies at 22Њ (see materials and methods), whereas the entry site at 12DE, the one that is flanked by GAGA Kelley et al. performed their crosses at 25Њ. When we repeated protein. As illustrated in Figure 5b , the 12DE entry site is our experiments at 25Њ, female viability was significantly reduced (data not shown). In addition, Kelley et al. stopped consistently absent in Trl Ϫ polytene chromosomes. This scoring their crosses 6 days after eclosion (see Figure 6e of effect is not due to a polymorphism at this site, since Kelley et al. 1995) , while we continued scoring for 11 days.
the strains were isogenic for their X chromosomes (see materials and methods). on the autosomes and X chromosome suggests that the distribution is abnormal and that some regions of the DISCUSSION X chromosome may not have wild-type levels of the Balancing gene expression from the sex chromosomes complex. This could arise, for example, if there were a and autosomes is a critical process in organisms with defect in the loading of MSL complexes at one or more sex differences in the number of sex chromosomes. In chromatin entry sites on the X chromosome. To investithe fruit fly D. melanogaster, one of the mechanisms used gate this possibility, we first compared the X chromoto equalize expression levels in the two sexes is the hyperacsome distribution of GAGA and MSL-complex entry tivation of X-linked genes in male animals. The male dossites ( Figure 5 ). Entry sites can be visualized because age compensation system upregulates transcription by they are bound by Msl1 and Msl2 proteins in mle, msl3, or mof mutant backgrounds (Gu et al. 1998; modifying the chromatin structure of X-linked genes. This is accomplished by a special multi-component comthan on female viability. In fact, the differences in the viability of the sexes in the two heteroallelic Trl mutant plex that preferentially localizes to the X chromosome. Complex assembly depends most critically upon Msl1 and combinations tested here are equivalent to, if not more pronounced than, those reported for mutations in jil-1 Msl2 and these two MSL proteins may provide some type of scaffold for recruiting/stabilizing other components of (Wang et al. 2001) . Second, as might be expected if the functioning of the dosage compensation system is the complex. These other components include the two noncoding RNAs, roX1 and roX2, which have been implicompromised when Trl function is impaired, we find that the male lethal effects of the two heteroallelic Trl cated in targeting the complex to entry sites on the X chromosome. In addition, the chromatin-modifying enmutant combinations are exacerbated by reductions in the dose of either msl1 or msl2. Moreover, although the zymes themselves, Mof-1, a histone acetylase, and JIL-1, a tandem histone kinase, the putative helicase, Mle, and the hypomorphic Trl 13C allele by itself exhibits no sex-specific lethality when homozygous, male-specific lethality Msl3 protein, are believed to associate with the complex through specific interactions. All but one of these factors can be induced by reducing the dose of the MSL complex. Conversely, increasing the level of the Msl2 gene appears to function primarily, if not exclusively, in the MSL dosage compensation system. The exception is the product using an hsp83 promoter to drive the expression of an msl2 cDNA partially rescues males carrying Trl JIL-1 kinase that is required not only for proper dosage compensation, but also for other aspects of transcriptional mutations.
Although Trl appears to function primarily in chromaregulation that are vital to both sexes. It would be reasonable to anticipate that other factors like JIL-1 that have tin remodeling rather than as a dedicated component of the transcriptional machinery, it is involved in the crucial activities in dosage compensation while at the same time functioning in other processes that are important expression of a very large and diverse array of genes. Since males must upregulate transcription of X-linked for both sexes will be identified. This seems to be true for the GAGA factor that is encoded by the Trl gene. genes to achieve the same level of expression as females, it would be reasonable to suppose that males are likely The importance of the GAGA factor in many aspects of gene regulation and chromatin dynamics has been to be much more dependent upon the proper functioning of the general transcriptional machinery than are extensively documented in previous studies (Biggin and Tjian 1988; Croston et al. 1991;  females. Accordingly, any reduction in the activity of a factor critical for transcription would be expected to Lu et al. 1993; Farkas et al. 1994; Tsukiyama et al. 1994; Bhat et al. 1996; Greenberg and Schedl 2001) . Evihave considerably more deleterious effects on males than on females. If this idea is correct, then the maledence presented here indicates that GAGA also has a more specialized role in X chromosome dosage comspecific lethality of Trl mutations could simply be due to a decline in the overall activity or efficiency of the pensation. First, heteroallelic combinations of weak and strong Trl mutations have much greater effects on male transcriptional machinery rather than to an effect spe- cific to the process of dosage compensation itself. This is that the GAGA factor plays some important role in the functioning or activity of the msl-dependent dosage "impaired transcription" model would also explain why the male-specific lethal effects of Trl mutations are encompensation system. In addition to accounting for both the male-specific lethality of Trl mutations and the hanced by a reduction in the dose of the msl genes and suppressed by increasing the dose of Msl2. Of course, genetic interactions between Trl and msl-complex genes, this suggestion would help explain two other findings. this model predicts that hypomorphic mutations in components of the transcriptional apparatus should also First, we observed abnormalities in the distribution of the MSL complexes in polytene chromosomes from Trl exhibit male-specific lethality like mutations in Trl. Although some alleles of TAF250 do cause preferential mutant males. These abnormalities include the presence of at least one ectopic site on the X chromosome and male lethality (D. Wassarman, personal communication), there is no evidence that compromising the activan increase in the number of autosomal sites. This redistribution of MSL complexes argues that the GAGA facity of other general transcription factors affects males more than females. In fact, none of the many hypomortor is important for correctly targeting the dosage compensation machinery to the X chromosome. A similar phic mutations in the gene coding for the 140-kD subunit of RNA polymerase II give rise to male lethality although more dramatic MSL redistribution was observed by Meller and Rattner ( roX2 were simultaneously deleted in males. Second, we found that one of the ‫53ف‬ chromatin entry sites on munication), and neither do mutations in the small subunit of TFIIA (Zeidler et al. 1996 ; M. Mlodzik, the X chromosome, at 12DE, is missing in Trl mutants. Unlike any of the other chromatin entry sites observed personal communication). An additional problem with the "impaired transcription" model is that it would not in polytene chromosomes, GAGA is localized to the 12DE site. This finding argues that the GAGA factor is account for the finding that Trl mutations enhance the female lethal effects of the hsp83:msl2 transgene. The important in the formation/maintenance of this particular chromatin entry site. Neither of these effects on opposite result would be expected, namely that Trl mutations would suppress the female lethal effects of ecthe chromosomal association of MSL complexes would be explained by a model in which the male-specific topic Msl2 protein.
An alternative, and we believe more plausible, explalethality of Trl mutations is due to some general reduction in the activity of the transcriptional machinery. nation for the effects of Trl mutations on male viability (green) and Msl2 (red) on the X chromosome of a female that carries two copies of H83M2-6I and is homozygous for msl3 to visualize the entry sites (Kelley et al. 1999) . (b) Absence of the entry site at 12DE in Trl mutants. Entry sites were visualized as in a, except that only one copy of the transgene was present. Only the Trl genotype was different between the lines as indicated on the panel. Msl2 is in red, DNA in blue.
While it would be reasonable to propose that there of MSL complexes in this region of the X chromosome in Trl mutants that are wild type for the MSL genes. is a direct connection between the defects in the chromosomal association of Msl complexes and male lethalOne explanation for this discrepancy is that defects in MSL-complex distribution in the vicinity of the 12DE ity, the precise mechanism is not entirely clear. One possibility is that male lethality is due to the loss of site are obscured because the recruitment and spreading of complexes is much more robust in polytene chrothe 12DE entry site. Supporting this idea, Kelley et al. (1999) have found that MSL complexes formed at mosomes (which consist of hundreds of chromosomes whose sequences are aligned in precise register) than ectopic entry sites on the autosomes usually spread only limited distances. This also appears to be true on the in chromosomes from polyploid or diploid nuclei. In fact, Kelley et al. (1999) have found that in polytene X chromosome (Oh et al. 2003) . It is thus possible that the two entry sites flanking 12DE, at 12C and 12F, would chromosomes MSL complexes can spread from ectopic entry sites on the autosomes not only in cis but also in be unable to compensate completely for the loss of the 12DE site. As a consequence, insufficient levels of the trans and can even skip over large chromosomal segments. MSL complex would be recruited into the 12C-12F interval in Trl mutant males to fully upregulate gene exThis simple model would also not explain why MSL complexes in polytenes of Trl mutants localize to many pression, and this might result in male lethality.
Although we believe that the loss of the 12DE entry ectopic sites on the autosomes. The presence of these autosomal complexes indicates that there must be some could significantly impair the upregulation of genes in the 12C-F interval, there are at least two potential comdefect in the loading of complexes onto the X chromosome. Since we do not see any obvious reduction in plications with this simple model. First, it seems unlikely that a reduction in the level of expression of genes in the amount of complex in the 12C-F interval, it seems unlikely that the loss of the 12DE entry site alone could the 12C-F interval would in itself be sufficient to cause male lethality. Unless this chromosomal interval conaccount for the presence of the autosomal complexes. Instead, this would suggest that the GAGA factor may tains genes specifically required for male viability (e.g., encoding components of the dosage compensation mabe important in the loading or spreading of complexes from a number of entry sites located elsewhere on the chinery), this model would predict that this same interval is haplo-insufficient in females. However, there is no X in addition to the 12DE entry site. In this respect, it is notable that the GAGA factor binds in close proximity indication that deletions in this chromosomal interval have significant effects on female viability. Second, while to five MSL-complex entry sites, including roX1. If GAGA is important in the loading or spreading of complexes the 12DE entry site is absent (in Trl; msl3 mutants), we do not see any obvious perturbation in the distribution from a number of "Trl-dependent" entry sites in addition to 12DE, the male lethal effects of the Trl would be exentry site. Given its role in generating nucleosome-free regions of chromatin, a plausible idea is that GAGA is plained by the cumulative effects of a reduction in the expression of genes located in several different chromorequired to ensure that the 12DE site is readily accessible to appropriate components of the MSL complex. In Trl somal regions rather than in just the 12C-F interval.
If loss of GAGA binding reduces the activity of only mutants, the 12DE entry site and/or the immediately surrounding DNA would be packaged into a nucleosoa subset of the chromatin entry sites, we would expect that dosage compensation would be compromised over mal structure that cannot be used to initiate MSL-complex assembly, is refractory to the assembly of stable complexes, some parts of the X chromosome, but not others. This would help to explain why the weak female lethal effects or is not compatible with the spreading of the complex in cis. The idea that a nucleosome-free region of chromatin is of the H83M2 transgene at 22Њ are greatly enhanced in Trl mutants. Under conditions in which Msl2 protein critical for entry site function is supported by recent studies of Kageyama et al. (2001) on the roX1 entry site. expression is limiting, defects in the spreading of MSL complexes from Trl-dependent entry sites could lead to They found that a small ‫-002ف‬bp sequence within the roX1 genes can direct the assembly of MSL complexes a more efficient loading and subsequent spreading from sites that are independent of Trl function. Female lethalat ectopic sites and that this sequence is hypersensitive to nuclease digestion in male but not female chromatin. ity would be induced because of the increased concentration of complexes in regions served by "Trl-indepenFurther correlating the formation of a nuclease hypersensitive site with the assembly of MSL complexes, Park dent" entry sites. A hint that this may happen comes from the study of Oh et al. (2003) , who found that et al. (2003) have recently shown that roX2 also has an internal sequence that functions to recruit MSL comelimination of one or the other of the roX chromatin entry sites results in a redistribution of the overexplexes and is hypersensitive in male but not in female flies. pressed Msl1 and Msl2 proteins to the other parts of the X chromosome.
In light of the effects of Trl mutations on male viability, it is interesting to note that the internal nuclease Finally, it is important to note that the effects on MSLcomplex distribution seen in salivary gland polytene hypersensitive site in the roX1 and roX2 genes harbors potential GAGA-factor-binding sites. Moreover, these chromosomes are unlikely to reproduce the defects in nonpolytene tissues that most directly contribute to potential GAGA-binding sites appear to be important for the entry site function of these elements (Park et male lethality. First, the available evidence suggests that GAGA interacts with different sites in different tissues al. 2003). However, we did not detect GAGA at roX2, and although GAGA does appear to be localized close (Bhat et al. 1996; Greenberg and Schedl 2001) . Hence, it is possible that the GAGA factor may be importo roX1, it did not significantly overlap with the roX1 Msl complex in our confocal experiments. In this case, tant for the formation or maintenance of entry sites in addition to 12DE in other cell types. Second, because why did we not detect GAGA protein at either the roX1 or the roX2 entry sites in polytene chromosomes? It is of a substantial maternal contribution, homozygous null Trl alleles are not lethal until larval stages, while the possible that the amount of GAGA factor at these two sites is too low for us to detect or that the protein is lethal phase of the hypomorphic mutant combinations used in the studies reported here is even later, during inaccessible to the GAGA antibody because of the Msl complex. Alternatively, the GAGA factor might be rethe pupal stage. It is likely that lethality occurs when the level of the GAGA factor becomes sufficiently dequired for the initial formation of the roX1/roX2 hypersensitive sites, but would then be largely displaced when pleted by successive rounds of cell division that it drops below a critical threshold in cells that are essential for the MSL complexes are assembled. In this case it would be required for establishment, not maintenance. Finally, viability. Since polytenized cells stop dividing, the level of GAGA factor may remain high enough in these cells it is also possible that it is not the GAGA factor but one of the other fly proteins that binds to the (GA) n /(CT) n to keep the functioning of the dosage compensation system from being seriously impaired. Third, GAGA is motifs in roX1 and roX2. Clearly, further studies will be required to resolve this question. known to bind to one of the major satellite sequences in centromeric heterochromatin (Raff et al. 1994) . Since
